GIC Sub-Industry »Biotechnology« (200+)
| Symbol | Industry | Market Cap | VRT | Buy Signal | Risk | RS (IBD) | Div. Yield |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie |
Biotechnology
Biologics, Immunology, Oncology |
385B | 52.1 | -1.17 | 37.6 | 60 | 4.30% |
| AMGN Amgen |
Biotechnology
Biologics, Biosimilars, Oncology |
187B | 69.5 | 0.88 | 63.1 | 76 | 3.21% |
| GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, HIV |
169B | 80.5 | 0.09 | 93.9 | 80 | 2.79% |
| VRTX Vertex |
Biotechnology
CF Modulators, Gene Therapy, Pain |
120B | 68.5 | -0.25 | 98 | 43 | - |
| REGN Regeneron |
Biotechnology
Eye, Dermatology, Asthma, Cancer |
80.1B | 72.0 | 0.37 | 99.7 | 80 | 0.54% |
| ARGX argenx |
Biotechnology
FcgRn-Blocker, MusK-Agonist |
49.5B | 62.0 | -0.18 | 36.2 | 74 | - |
| ALNY Alnylam |
Biotechnology
ONPATTRO, AMVUTTRA, GIVLAARI |
47.3B | 45.8 | -0.89 | 0 | 43 | - |
| HLN Haleon |
Biotechnology
Toothpaste, Vitamins, Cold-Relief |
46.6B | 59.4 | -0.45 | 100 | 50 | 1.76% |
| ONC BeiGene |
Biotechnology
BTK Inhibitor, PD-1 Antibody, PARP |
37.5B | 55.7 | -0.34 | 0 | 77 | - |
| NTRA Natera |
Biotechnology
Panorama, Horizon, Vistara |
33.9B | 54.5 | 0.41 | 0 | 89 | - |
| INSM Insmed |
Biotechnology
Liposomal Antibiotic, DPP1 |
33.3B | 47.2 | -0.15 | 0 | 91 | - |
| 22UA BioNTech SE |
Biotechnology
Cancer Vaccines, Immunotherapies |
29.7B | 29.0 | -0.30 | 95.2 | 31 | - |
| BNTX BioNTech SE |
Biotechnology
Cancer Immunotherapies |
26.5B | 34.8 | -1.24 | 99.3 | 46 | - |
| BIIB Biogen |
Biotechnology
Multiple Sclerosis, Spinal |
25.2B | 71.8 | -0.39 | 100 | 79 | - |
| RVMD Revolution |
Biotechnology
RAS Inhibitors, Companion |
23.0B | 39.5 | 1.13 | - | 97 | - |
| UTHR United Therapeutics |
Biotechnology
Treprostinil, Orenitram, Unituxin |
21.2B | 83.7 | 0.53 | 100 | 84 | - |
| GMAB Genmab AS |
Biotechnology
Antibody Therapies, Oncological |
21.0B | 81.6 | 0.28 | 100 | 87 | - |
| INCY Incyte |
Biotechnology
JAKAFI, MONJUVI, PEMAZYRE |
20.0B | 88.3 | 0.14 | 100 | 85 | - |
| MRNA Moderna |
Biotechnology
Vaccines, Respiratory, Oncology |
19.1B | 36.3 | -0.08 | 0 | 92 | - |
| ROIV Roivant Sciences |
Biotechnology
Antibody, Small-Molecule, Inhaled |
16.0B | 53.4 | 1.77 | - | 93 | - |
| RGC Regencell |
Biotechnology
Herbal, Capsule, Syrup, Extract |
15.5B | 29.3 | -0.62 | - | 99 | - |
| BBIO BridgeBio Pharma |
Biotechnology
ATTR-CM, Achondroplasia |
15.3B | 48.8 | 1.46 | 0 | 93 | - |
| ERF Eurofins |
Biotechnology
Testing, Laboratory, Diagnostics |
15.1B | 65.4 | -1.06 | 91.6 | 77 | 1.12% |
| BIM Biomerieux |
Biotechnology
Chromogenic Media, Blood Culture |
14.6B | 64.0 | -1.47 | 93.2 | 13 | 0.74% |
| ASND Ascendis Pharma AS |
Biotechnology
TransCon, Hormone, Parathyroid |
14.4B | 50.0 | 1.19 | 0 | 87 | - |
| NBIX Neurocrine |
Biotechnology
Movement, Endocrine, Psychiatric |
13.6B | 56.2 | -0.69 | 90.9 | 22 | - |
| IONS Ionis |
Biotechnology
RNA-Targeted, Neurological, Rare |
13.2B | 47.9 | 0.68 | 35.1 | 95 | - |
| SMMT Summit Therapeutics |
Biotechnology
Ivonescimab, Bispecific Antibody |
12.0B | 7.6 | -1.04 | - | 6 | - |
| EXEL Exelixis |
Biotechnology
Cancer, Medicines, Tablets |
11.8B | 82.5 | 0.18 | 95.2 | 61 | - |
| RNA Avidity Biosciences |
Biotechnology
RNA Therapeutics, Antibody |
11.0B | 34.0 | 1.51 | 0 | 94 | - |
| MDGL Madrigal |
Biotechnology
Rezdiffra, MASH, Thyroid |
10.9B | 48.9 | 0.31 | 0 | 88 | - |
| BMRN Biomarin |
Biotechnology
Enzyme Replacement, Growth |
10.8B | 53.0 | -1.17 | 98.6 | 22 | - |
| ARWR Arrowhead |
Biotechnology
Plozasiran, Zodasiran |
9.35B | 59.0 | 0.75 | - | 99 | - |
| PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.65B | 35.0 | -0.06 | - | 99 | - |
| KRYS Krystal Biotech |
Biotechnology
Gene Therapy, Rare Skin Diseases |
8.38B | 66.3 | 1.04 | 87.2 | 92 | - |
| HALO Halozyme |
Biotechnology
Enzyme, Injection, Antibody |
8.28B | 86.7 | -0.97 | 100 | 65 | - |
| ABVX Abivax |
Biotechnology
Immunomodulator Candidate, Bowel |
8.26B | 47.5 | -0.20 | 0 | 99 | - |
| ABVX Abivax American |
Biotechnology
Drug Candidate, Phase 3, Phase 2b |
8.19B | 47.5 | -0.02 | 0 | 99 | - |
| CYTK Cytokinetics |
Biotechnology
Cardiac Activator, Cardiac |
7.75B | 36.8 | 0.21 | 0 | 83 | - |
| NUVL Nuvalent |
Biotechnology
Ros1 Inhibitor, Alk Inhibitor |
7.74B | 28.6 | 0.04 | - | 77 | - |
| GRFS Grifols |
Biotechnology
Immunoglobulin, Albumin, Clotting |
7.65B | 47.7 | -1.21 | 81.3 | 52 | 1.63% |
| PCVX Vaxcyte |
Biotechnology
Pneumococcal, Streptococcus |
6.90B | 20.5 | -0.03 | - | 75 | - |
| RYTM Rhythm |
Biotechnology
Imcivree, Setmelanotide, Obesity |
6.87B | 46.5 | -0.37 | 0 | 82 | - |
| GPCR Structure |
Biotechnology
Obesity, Diabetes, Pulmonary |
6.49B | 35.3 | 0.57 | - | 99 | - |
| BLTE Belite Bio |
Biotechnology
Tinlarebant, LBS-009, Retinal |
6.17B | 34.7 | 0.86 | - | 97 | - |
| PTCT PTC Therapeutics |
Biotechnology
Translarna, Emflaza, Upstaza |
6.04B | 79.2 | -0.03 | 66.8 | 88 | - |
| COGT Cogent Biosciences |
Biotechnology
Bezuclastinib, CGT4859, Kinase |
5.63B | 44.1 | 0.12 | - | 99 | - |
| KYMR Kymera Therapeutics |
Biotechnology
IRAK4, STAT6, TYK2, Protein |
5.59B | 38.4 | 0.47 | 0 | 91 | - |
| CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
5.45B | 37.3 | 0.46 | 0 | 87 | - |
| IBRX Immunitybio |
Biotechnology
Immunotherapy, Cytokine-Fusion |
5.44B | 62.2 | -1.03 | 0 | 97 | - |
| CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, CAR-T |
5.29B | 19.3 | -0.68 | 0 | 40 | - |
| IMVT Immunovant |
Biotechnology
Monoclonal Antibodies, Autoimmune |
5.24B | 32.1 | 0.79 | 0 | 87 | - |
| ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
5.22B | 72.8 | -0.38 | 86.4 | 65 | - |
| PTGX Protagonist |
Biotechnology
Peptide, Hepcidin, Integrin |
5.20B | 53.6 | -0.22 | 0 | 91 | - |
| CELC Celcuity |
Biotechnology
Gedatolisib, CELsignia, PI3K |
5.13B | 35.6 | 1.86 | - | 99 | - |
| TGTX TG Therapeutics |
Biotechnology
Briumvi, Ublituximab, Tg-1701 |
4.95B | 46.6 | -1.17 | 0 | 11 | - |
| MIRM Mirum |
Biotechnology
Livmarli, Cholbam, Chenodal |
4.87B | 55.6 | 0.53 | 17.5 | 94 | - |
| APGE Apogee |
Biotechnology
Monoclonal Antibodies, Atopic |
4.78B | 33.4 | 0.44 | - | 91 | - |
| ACAD ACADIA |
Biotechnology
Pimavanserin, Trofinetide |
4.54B | 59.1 | 0.25 | 0 | 85 | - |
| SRRK Scholar Rock |
Biotechnology
Antibody, Myostatin-Inhibitor |
4.52B | 22.2 | -0.12 | - | 83 | - |
| CGON CG Oncology |
Biotechnology
Bladder Cancer, Oncolytic |
4.45B | 36.4 | 0.54 | 0 | 92 | - |
| INDV Indivior Ordinary |
Biotechnology
Buprenorphine, Sublingual |
4.19B | 75.0 | 0.96 | 57.6 | 96 | - |
| GRAL GRAIL |
Biotechnology
Cancer Test, Diagnostic Aid |
4.09B | 39.8 | 0.58 | 0 | 98 | - |
| LEGN Legend Biotech |
Biotechnology
CAR-T Therapy, Multiple Myeloma |
4.09B | 22.1 | -1.50 | 0 | 2 | - |
| ADMA ADMA Biologics |
Biotechnology
Immunoglobulin, Hepatitis |
3.99B | 53.1 | -0.21 | 0 | 20 | - |
| LGND Ligand |
Biotechnology
Vaccines, Antivirals, Oncology |
3.96B | 56.6 | -0.28 | 91.7 | 87 | - |
| ACLX Arcellx |
Biotechnology
DdCAR, Anitocabtagene Autoleucel |
3.91B | 17.3 | -0.66 | - | 17 | - |
| VKTX Viking Therapeutics |
Biotechnology
VK2809, VK5211, VK0612, VK2735 |
3.83B | 9.3 | -1.14 | - | 21 | - |
| NAMS NewAmsterdam |
Biotechnology
Obicetrapib, Ezetimibe, LDL-C |
3.78B | 43.9 | -0.99 | 0 | 81 | - |
| CNTA Centessa |
Biotechnology
Sleep Disorder Drug, Ox2R Agonist |
3.74B | 45.4 | -0.61 | 0 | 89 | - |
| BEAM Beam Therapeutics |
Biotechnology
Base Editing Therapies |
3.48B | 25.7 | 0.32 | - | 83 | - |
| VERA Vera Therapeutics |
Biotechnology
Atacicept, MAU868, VT-109 |
3.46B | 33.9 | 0.78 | - | 94 | - |
| VCYT Veracyte |
Biotechnology
Thyroid, Prostate, Bladder |
3.34B | 49.4 | -0.78 | 0 | 75 | - |
| XENE Xenon |
Biotechnology
Epilepsy, Depression, Bipolar |
3.23B | 24.0 | 0.16 | 90.9 | 55 | - |
| KNSA Kiniksa |
Biotechnology
ARCALYST, Vixarelimab, KPL-387 |
3.20B | 61.3 | 0.69 | 15.8 | 91 | - |
| IDYA Ideaya Biosciences |
Biotechnology
Kinase, Helicase, PARP, ADC |
3.17B | 44.5 | 0.40 | 0 | 84 | - |
| ARQT Arcutis |
Biotechnology
Topical Cream, Topical Foam, JAK1 |
3.17B | 49.9 | 0.22 | 0 | 92 | - |
| DNLI Denali Therapeutics |
Biotechnology
RIPK1 Inhibitor, eIF2B Activator |
3.16B | 21.0 | 0.59 | - | 78 | - |
| VRDN Viridian |
Biotechnology
Monoclonal Antibody, IGF-1R |
3.14B | 46.6 | 1.08 | 0 | 94 | - |
| ALMS Alumis |
Biotechnology
TYK2 Inhibitor, CNS TYK2 |
3.06B | 45.0 | 1.10 | - | 99 | - |
| EWTX Edgewise |
Biotechnology
EDG-5506, EDG-7500, Pipeline |
3.03B | 30.7 | 0.13 | - | 93 | - |
| DYN Dyne Therapeutics |
Biotechnology
Therapeutics, Neuromuscular |
2.96B | 35.3 | -0.43 | - | 80 | - |
| ERAS Erasca |
Biotechnology
Naporafenib, ERAS-007, ERAS-601 |
2.92B | 43.0 | 0.60 | 0 | 99 | - |
| CPRX Catalyst |
Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree |
2.90B | 69.9 | -0.12 | 88.3 | 51 | - |
| IRON Disc Medicine |
Biotechnology
Bitopertin, DISC-0974, DISC-3405 |
2.88B | 39.9 | -0.18 | - | 75 | - |
| IMNM Immunome |
Biotechnology
Gamma Secretase Inhibitor |
2.85B | 34.6 | 0.44 | - | 97 | - |
| APLS Apellis |
Biotechnology
EMPAVELI, SYFOVRE, Pegcetacoplan |
2.75B | 38.5 | -0.49 | 0 | 15 | - |
| RCUS Arcus Biosciences |
Biotechnology
Cancer, Antibody, Inhibitor |
2.74B | 47.8 | 0.05 | 0 | 94 | - |
| TVTX Travere |
Biotechnology
Filspari, Thiola, Sparsentan |
2.63B | 48.8 | 0.15 | 0 | 87 | - |
| TWST Twist Bioscience |
Biotechnology
Synthetic Genes, Oligo Pools, NGS |
2.63B | 30.0 | -0.03 | 0 | 54 | - |
| MLYS Mineralys |
Biotechnology
Aldosterone Synthase Inhibitor |
2.59B | 39.3 | -0.35 | - | 96 | - |
| SYRE Spyre Therapeutics |
Biotechnology
Antibody, Integrin, TL1A, IL-23 |
2.49B | 33.7 | 0.08 | - | 93 | - |
| RXRX Recursion |
Biotechnology
REC-994, REC-2282, REC-4881 |
2.47B | 12.5 | -1.19 | 0 | 6 | - |
| RARE Ultragenyx |
Biotechnology
Enzyme, Gene, Antibody, Metabolic |
2.34B | 21.1 | -0.92 | 0 | 5 | - |
| GLPG Galapagos |
Biotechnology
Oncology, Immunology, CAR-T |
2.29B | 48.5 | -1.17 | 85.6 | 62 | - |
| SLNO Soleno Therapeutics |
Biotechnology
Diazoxide, Prader-Willi, Rare |
2.28B | 18.4 | -0.97 | - | 4 | - |
| GLPG Galapagos |
Biotechnology
CAR-T, Oncology, Immunology |
2.27B | 50.9 | -0.30 | 100 | 74 | - |
| DNTH Dianthus |
Biotechnology
Monoclonal Antibody, Complement |
2.24B | 46.9 | 0.68 | 0 | 96 | - |
| SRPT Sarepta |
Biotechnology
Exon-Skipping Injectables, Gene |
2.20B | 24.5 | 0.44 | 0 | 9 | - |
| ZLAB Zai Lab |
Biotechnology
Oncology, Immunology, Neurology |
2.03B | 23.4 | -1.72 | 0 | 3 | - |
| NUVB Nuvation Bio |
Biotechnology
Taletrectinib, Safusidenib |
2.03B | 45.1 | 0.23 | 0 | 94 | - |
| OLMA Olema |
Biotechnology
Palazestrant, OP-3136 |
2.02B | 35.3 | -0.53 | 0 | 99 | - |
| MESO Mesoblast |
Biotechnology
Cell Therapy, Stem Cell |
1.94B | 22.3 | -0.17 | 33.8 | 75 | - |
| AUPH Aurinia |
Biotechnology
Immunosuppressant, B-Cell Inhibitor |
1.92B | 84.7 | 0.26 | 81.5 | 91 | - |
| VCEL Vericel Ord |
Biotechnology
Cartilage, Skin, Burns, Therapy |
1.91B | 36.2 | -0.66 | 84 | 14 | - |
| ZBIO Zenas BioPharma |
Biotechnology
Obexelimab, ZB002, ZB004, ZB001 |
1.91B | 32.8 | -0.79 | - | 88 | - |
| ARDX Ardelyx |
Biotechnology
Ibs-Constipation |
1.89B | 49.6 | -0.05 | 0 | 91 | - |
| NRIX Nurix Therapeutics |
Biotechnology
BTK Degrader, CBL-B Inhibitor |
1.88B | 28.2 | -0.25 | 0 | 89 | - |
| SION Sionna |
Biotechnology
Galicaftor, Navocaftor, SION-109 |
1.86B | 34.4 | 0.32 | - | 96 | - |
| BHVN Biohaven |
Biotechnology
Neurology, Immunology, Oncology |
1.83B | 12.2 | -1.57 | - | 4 | - |
| PHVS Pharvaris BV |
Biotechnology
Deucrictibant, Oral Capsule, Oral |
1.82B | 32.5 | 0.49 | - | 87 | - |
| IMCR Immunocore Holdings |
Biotechnology
Kimmtrak, Tebentafusp |
1.77B | 30.1 | -0.35 | 73.1 | 44 | - |
| ZYME Zymeworks Common |
Biotechnology
Bispecific Antibodies |
1.77B | 46.9 | -0.01 | 15.9 | 90 | - |
| SNDX Syndax |
Biotechnology
Menin Inhibitor, CSF-1R Antibody |
1.76B | 47.6 | 1.22 | 0 | 93 | - |
| GLUE Monte Rosa |
Biotechnology
MGD Pipeline, MRT-2359, MRT-6160 |
1.76B | 67.4 | 0.25 | 0 | 99 | - |
| CLDX Celldex |
Biotechnology
Monoclonal Antibody, Bispecific |
1.72B | 18.6 | 0.27 | 0 | 51 | - |
| MBX MBX Biosciences |
Biotechnology
Peptide Prodrug, GLP-1 Antagonist |
1.70B | 35.2 | 0.21 | - | 99 | - |
| NTLA Intellia |
Biotechnology
Gene Editing, In Vivo, CAR-T, NK |
1.69B | 30.3 | -0.90 | 0 | 71 | - |
| RAPT RAPT Therapeutics |
Biotechnology
Zelnecirnon, Tivumecirnon, CCR4 |
1.67B | 35.0 | 0.64 | - | 99 | - |
| ORKA Oruka Therapeutics |
Biotechnology
Monoclonal Antibody |
1.66B | 34.6 | 0.30 | - | 97 | - |
| AGIO Agios Pharm |
Biotechnology
Pyrimidine Kinase Activator |
1.66B | 20.4 | -0.22 | 0 | 8 | - |
| TNGX Tango Therapeutics |
Biotechnology
PRMT5 Inhibitors, Brain-Penetrant |
1.66B | 47.5 | 0.58 | - | 99 | - |
| TYRA Tyra Biosciences |
Biotechnology
FGFR, Precision, Platform |
1.65B | 42.9 | 1.58 | 0 | 98 | - |
| STOK Stoke Therapeutics |
Biotechnology
Dravet Syndrome, Optic Atrophy |
1.64B | 65.6 | -0.21 | 0 | 96 | - |
| ALVO Alvotech |
Biotechnology
Biosimilar, Autoimmune, Oncology |
1.64B | 23.5 | -0.42 | 0 | 3 | - |
| KOD Kodiak Sciences |
Biotechnology
Anti-VEGF Biopolymer, Anti-Il6 |
1.58B | 36.5 | 0.27 | - | 99 | - |
| OCS Oculis Holding |
Biotechnology
Topical Steroid, Biologic |
1.57B | 30.0 | 0.48 | 0 | 84 | - |
| QURE Uniqure |
Biotechnology
Hemophilia Gene Therapy |
1.56B | 41.3 | -0.47 | 0 | 68 | - |
| MNKD MannKind |
Biotechnology
Inhaled Insulin, Insulin Pump |
1.56B | 45.0 | 0.04 | 0 | 57 | - |
| MEDCL Medincell |
Biotechnology
Antipsychotic, Analgesic |
1.51B | 54.0 | -1.25 | 0 | 81 | - |
| ATAI ATAI Life Sciences |
Biotechnology
Depression Treatment |
1.51B | 33.4 | -0.83 | 0 | 91 | - |
| NVAX Novavax |
Biotechnology
Covid-19 Vaccine, Nanoparticle |
1.49B | 44.1 | -0.41 | 0 | 73 | - |
| BTX BlackRock |
Biotechnology
Technology, Private Equity, Mutual |
1.44B | 15.6 | -1.41 | - | 27 | 13.81% |
| NNNN Anbio |
Biotechnology
Antigen, Immunoassay |
1.43B | 72.8 | -2.28 | - | 96 | - |
| BCRX BioCryst |
Biotechnology
Antiviral, HAE, Complement, Factor |
1.40B | 46.5 | -1.43 | 0 | 12 | - |
| PHARM Pharming |
Biotechnology
Recombinant C1-Inhibitor, Oral |
1.38B | 62.0 | 0.06 | 52.4 | 95 | - |
| PGEN Precigen |
Biotechnology
Gene Therapy, Cell Therapy |
1.36B | 39.2 | -0.04 | 0 | 98 | - |
| ANAB AnaptysBio |
Biotechnology
Rosnilimab, ANB032, ANB033 |
1.33B | 35.7 | 0.95 | 0 | 95 | - |
| IMTX Immatics |
Biotechnology
TCR Bispecifics, ACT Cell |
1.33B | 37.7 | -0.39 | 0 | 88 | - |
| IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, Tgf-Beta |
1.30B | 48.2 | -0.30 | 0 | 96 | - |
| SANA Sana Biotechnology |
Biotechnology
Islet Cell Therapy, CAR-T Cell |
1.29B | 32.0 | 0.14 | - | 86 | - |
| TSHA Taysha Gene |
Biotechnology
Gene Therapy, Neurological |
1.28B | 46.7 | -0.21 | - | 95 | - |
| RLAY Relay Therapeutics |
Biotechnology
RLY-2608, RLY-4008, RLY-8161 |
1.27B | 46.1 | 0.00 | - | 92 | - |
| ABCL Abcellera Biologics |
Biotechnology
Antibody, Drug, Candidate |
1.27B | 24.8 | -0.50 | 100 | 27 | - |
| CAPR Capricor |
Biotechnology
Deramiocel, Exosome Vaccine |
1.26B | 36.2 | -0.24 | 0 | 99 | - |
| UPB Upstream Bio |
Biotechnology
Asthma, Polyps, Copd |
1.26B | 47.1 | 0.53 | 0 | 97 | - |
| CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous, Esophagus |
1.23B | 56.0 | 1.00 | 45.8 | 96 | - |
| DAWN Day One |
Biotechnology
Tovorafenib, Day301, Vrk1 Inhibitor |
1.23B | 35.8 | 0.21 | 0 | 89 | - |
| SVRA Savara |
Biotechnology
Inhaled Immunostimulant, Orphan |
1.22B | 34.0 | -0.35 | - | 94 | - |
| MLTX MoonLake |
Biotechnology
Sonelokimab, Nanobody, IL-17A |
1.19B | 7.1 | -0.87 | 0 | 10 | - |
| ORIC Oric |
Biotechnology
Kinase Inhibitor, AR Pathway, CD73 |
1.17B | 26.8 | -0.27 | - | 82 | - |
| DBVT DBV Technologies |
Biotechnology
Viaskin Peanut, Viaskin Milk |
1.13B | 36.1 | -0.11 | 0 | 98 | - |
| PVLA Palvella |
Biotechnology
Rapamycin Gel, Rare Dermatology |
1.09B | 35.0 | 0.26 | - | 99 | - |
| CDNA CareDx |
Biotechnology
AlloSure, AlloMap, AlloSeq |
1.09B | 47.6 | 0.58 | 0 | 83 | - |
| NANO Nanobiotix S.A |
Biotechnology
Nanoparticle Radiotherapy |
1.06B | 50.0 | -0.16 | 0 | 99 | - |
| VIR Vir Biotechnology |
Biotechnology
Antibodies, Vaccines, T-Cell |
1.05B | 18.3 | -0.07 | 0 | 64 | - |
| IOVA Iovance |
Biotechnology
Amtagvi, Proleukin, Lifileucel |
1.05B | 17.1 | -0.46 | 0 | 18 | - |
| CMPX Compass |
Biotechnology
Trocimig, CTX-471, CTX-8371 |
1.05B | 46.2 | 1.13 | - | 96 | - |
| OPK Opko Health |
Biotechnology
Diagnostics, Rayaldee, 4Kscore |
1.05B | 18.8 | -0.82 | 0 | 14 | - |
| GHRS GH Research |
Biotechnology
Mebufotenin, Inhalable |
1.04B | 32.6 | -0.43 | - | 87 | - |
| ANNX Annexon |
Biotechnology
Antibody, Fragment, Oral |
1.04B | 45.2 | 1.01 | - | 98 | - |
| NBTX Nanobiotix |
Biotechnology
Nanoparticle-Based Radiotherapy |
1.01B | 63.3 | -0.39 | 0 | 99 | - |
| SPRY ARS |
Biotechnology
Nasal Epinephrine Spray |
1.01B | 20.9 | -0.72 | 0 | 10 | - |
| BBOT BridgeBio Oncology |
Biotechnology
KRAS Inhibitor, HER2 Therapy |
1.01B | 44.7 | -0.30 | - | 73 | - |
| AVBP ArriVent |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
958M | 16.0 | 0.09 | - | 53 | - |
| CTMX CytomX Therapeutics |
Biotechnology
Antibody-Drug Conjugate, T-Cell |
939M | 68.8 | 0.40 | 0 | 99 | - |
| URGN UroGen Pharma |
Biotechnology
Jelmyto, UGN-102, UGN-103 |
936M | 47.6 | 0.28 | 0 | 87 | - |
| BCAX Bicara |
Biotechnology
Ficerafusp Alfa, Bifunctional |
917M | 28.1 | -0.14 | - | 68 | - |
| XNCR Xencor |
Biotechnology
Monoclonal Antibodies, Bispecific |
913M | 24.3 | -0.49 | 0 | 33 | - |
| DRUG Bright Minds |
Biotechnology
Serotonin Agonists, Epilepsy |
897M | 39.6 | 0.63 | - | 97 | - |
| JANX Janux Therapeutics |
Biotechnology
TRACTr, TRACIr, JANX007, JANX008 |
891M | 20.9 | -0.80 | 0 | 2 | - |
| GERN Geron |
Biotechnology
Telomerase Inhibitor, Oncology |
881M | 22.5 | -1.07 | 0 | 18 | - |
| IRWD Ironwood |
Biotechnology
Linaclotide, Apraglutide, IW-3300 |
851M | 78.4 | 0.61 | 0 | 99 | - |
| VLA Valneva SE |
Biotechnology
Vaccines, Chikungunya, Lyme, Zika |
844M | 47.1 | -1.45 | 0 | 79 | - |
| ENGN enGene Holdings |
Biotechnology
Bladder Cancer Therapy, Gene |
815M | 34.5 | 0.07 | - | 96 | - |
| KALV Kalvista |
Biotechnology
Plasma Kallikrein Inhibitor, Oral |
810M | 36.8 | -0.22 | 0 | 83 | - |
| PRME Prime Medicine |
Biotechnology
Gene Editing, Prime Editor |
800M | 27.7 | -1.11 | - | 83 | - |
| ABUS Arbutus Biopharma |
Biotechnology
RNAi Therapy, PD-L1 Inhibitor, HBV |
781M | 27.3 | -0.38 | 0 | 50 | - |
| MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
780M | 55.1 | -1.45 | 99 | 6 | - |
| KURA Kura Oncology |
Biotechnology
Ziftomenib, Tipifarnib, KO-2806 |
751M | 43.6 | -1.12 | 0 | 43 | - |
| ESPR Esperion |
Biotechnology
Bempedoic Acid, Ezetimibe |
744M | 57.4 | 0.14 | 0 | 95 | - |
| CGEM Cullinan Oncology |
Biotechnology
Zipalertinib, CLN-978, CLN-619 |
738M | 27.6 | -0.06 | - | 88 | - |
| SLS Sellas Life |
Biotechnology
Cancer Immunotherapy, CDK9 |
725M | 34.8 | -0.25 | - | 98 | - |
| ATXS Astria Therapeutics |
Biotechnology
Navenibart, STAR-0310, Monoclonal |
718M | 43.6 | -0.19 | - | 92 | - |
| RGNX Regenxbio |
Biotechnology
Gene Therapy, Retinal Diseases |
698M | 43.7 | 0.49 | 0 | 86 | - |
| RIGL Rigel |
Biotechnology
Kinase Inhibitor, Blood Disorder |
671M | 85.0 | -0.44 | 0 | 92 | - |
| MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapy, Ocular |
652M | 32.1 | -0.89 | 0 | 38 | - |
| PROK ProKidney |
Biotechnology
Autologous Selected Renal Cells |
644M | 31.7 | -1.36 | - | 47 | - |
| VOR Vor Biopharma |
Biotechnology
Trem-Cel, VCAR33, CD33-CLL1 |
642M | 10.9 | -1.43 | - | 3 | - |
| LENZ LENZ Therapeutics |
Biotechnology
Ophthalmic, Presbyopia, Phase III |
640M | 16.1 | -0.69 | - | 5 | - |
| GOSS Gossamer Bio |
Biotechnology
Seralutinib, GB002 |
625M | 48.0 | -0.33 | 0 | 95 | - |
| LXRX Lexicon |
Biotechnology
Sotagliflozin, LX9211, LX9851 |
618M | 45.7 | -0.78 | 0 | 90 | - |
| REPL Replimune |
Biotechnology
Oncolytic Immunotherapy, RP1, RP2 |
605M | 19.3 | -1.16 | 0 | 45 | - |
| CRVS Corvus |
Biotechnology
ITK Inhibitor, A2A Antagonist |
601M | 40.0 | -0.41 | 0 | 99 | - |
| DRTS Alpha Tau Medical |
Biotechnology
Alpha, DaRT, Radiation, Therapy |
596M | 34.5 | 1.06 | - | 96 | - |
| IVVD Invivyd |
Biotechnology
Antibody, Covid-19, Influenza |
595M | 48.5 | -0.83 | 0 | 98 | - |
| EBS Emergent |
Biotechnology
Vaccines, Antitoxins |
586M | 48.4 | 0.45 | 94 | 90 | - |
| KROS Keros Therapeutics |
Biotechnology
KER-050, KER-012, KER-065 |
585M | 61.4 | -0.10 | 0 | 85 | - |
| KYTX Kyverna |
Biotechnology
CD19 CAR T-Cell, Autologous |
582M | 34.9 | 0.13 | - | 97 | - |
| DSGN Design Therapeutics |
Biotechnology
GeneTAC, Friedreich, Ataxia |
580M | 34.4 | 1.80 | 0 | 96 | - |